GSA Capital Partners’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
GSA Capital Partners's ORGO Position: Q3 2026 in Review
GSA Capital Partners opened a new position in Organogenesis Holdings (ORGO) in Q3 2026: 398,237 shares worth $546K. The stake represents 0.03% of the portfolio and ranks #987 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in ORGO as recently as Q1 2026.
GSA Capital Partners first reported a position in ORGO in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.48M in Q2 2024. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- GSA Capital Partners held 398,237 shares of Organogenesis Holdings worth $546K as of Q3 2026.
- Organogenesis Holdings was a new GSA Capital Partners position in Q3 2026.
- Organogenesis Holdings made up 0.03% of GSA Capital Partners's portfolio in Q3 2026, its #987 holding.
- GSA Capital Partners first reported a position in Organogenesis Holdings in Q3 2020 and has held it in 17 quarters since.
- GSA Capital Partners's Organogenesis Holdings position peaked at $2.48M in Q2 2024.
- 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.